Showing results (121-130 of 214) with videos related to
Sort By:
Pageof 22
Signal Transduction and Targeted Therapy|November 27, 2025
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challengesKhalil Choucair, Hafsa Imtiaz, Md Hafiz Uddin, et al.Investigational New Drugs|July 22, 2005
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancerBasil F El-Rayes, Mark M Zalupski, Anthony F Shields, et al.Oncotarget|November 16, 2017
Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migrationAsfar S Azmi, Yiwei Li, Irfana Muqbil, et al.European Journal of Cancer (Oxford, England : 1990)|February 17, 2010
MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 functionAsfar S Azmi, Amro Aboukameel, Sanjeev Banerjee, et al.The Oncologist|June 6, 2018
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric AdenocarcinomaMohamed E Salem, Alberto Puccini, Joanne Xiu, et al.Cancer Chemotherapy and Pharmacology|April 13, 2007
Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancerBassel F El-Rayes, Mark M Zalupski, Stephanie G Manza, et al.Current Cancer Drug Targets|April 8, 2010
Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, A Aboukameel, et al.Cancer|July 22, 2014
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)Philip A Philip, Bryan Goldman, Ramesh K Ramanathan, et al.Oncotarget|November 22, 2017
Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancersMohamed E Salem, Benjamin A Weinberg, Joanne Xiu, et al.International Journal of Molecular Sciences|October 2, 2019
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric CancerRachel Sexton, Zaid Mahdi, Rahman Chaudhury, et al.Pageof 22